The Novel Use of Subdermal Implant Containing Etonogestrel Progestogen (ImplanonR) for the Treatment of a Difficult and Recurrent Case of Abdominal Wall Endometriosis, a Case Report

Background: Abdominal wall endometriosis is to be found to increase due to the rapid increase of caesarean section rates. The Case: The author report a case of a 44 year old multiparous woman diagnosed with recurrent abdominal wall endometriosis after cesarean section few years ago for which she underwent wide surgical excision and was treated medically with GnRH agonists with no long term improvement. The case was successfully treated with a novel use of subdermal implant containing etonogestrel progestogen (ImplanonR) with the addition of oral progestogen. After one year follow up; the patient is pain free and the mass has substantially reduced in size. The patient had some troubles with occasional breakthrough bleeding episodes which were treated in addition to some weight gain. Conclusion: The use of subdermal implants can be used as an option for the treatment of abdominal wall endometriosis. However, more studies on more cases are needed.